Alembic Pharma Share Price

NSE: APLLTD
|
Pharmaceuticals

₹ 792.45

-₹5.40 (-0.68%)
1D
Last updated 14 Oct, 2026, 15:55 IST

Alembic Pharma Share Price Today

As of 14 Oct 2026, Alembic Pharma share price is ₹792.45. The stock opened at ₹789.05, compared to its previous close of ₹797.85. During today's trading session, Alembic Pharma share price moved in the range of ₹785.80 to ₹799.15, with an average price of ₹792.47 for the day. Looking at its last 52-week, the stock has touched a low of ₹635.80 and a high of ₹998.00. On the performance front, Alembic Pharma share price has increased by 11.20% over the last six months and is down 15.46% on a year-on-year basis.

₹785.80
0.68% down today
₹799.15
1D LOW
1D HIGH

Alembic Pharma Returns Calculator

Volume
70,461
Average traded price
₹792.24
Last traded time
03:55:19 14 Oct
Last traded quantity
1
Circuit
L
H
₹638.30
₹957.40
52-week
L
H
₹635.80
₹998.00
Mkt Cap Cr
15,668.05
P/E
22.72
P/B
2.76
ROA
7.87%
ROE
11.89%
ROCE
10.81%
Quick Ratio
0.78
EV/EBITDA
14.36
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Alembic Pharma has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Alembic Pharma appears overvalued compared to its peers
Step 4 of 5
Earnings
Good
Alembic Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0135.035.0811.19%13.74%17.33%2.3121.42
Divis Laboratories2,46,222.1184.1814.6914.6%15.32%19.56%3.556.81
Torrent Pharmaceuticals1,76,300.5081.7720.964.87%25.49%13.85%0.7538.3
Zydus Lifesciences1,12,817.6824.574.168.57%18.59%17.35%0.9115.07
Laurus Labs1,11,898.66101.6420.9110.38%16.77%16.14%0.6854.71
Cipla1,06,129.9632.023.127.92%11.27%14.95%2.517.97
Dr. Reddy's Laboratories1,03,471.1432.52.725.48%11.07%12.54%1.3516.27
Mankind Pharma99,089.5247.326.07.36%11.74%13.13%0.7426.02
Aurobindo Pharma96,836.1026.12.566.34%9.25%11.76%1.1512.57
Lupin89,628.8316.153.9914.47%23.76%24.88%1.429.46

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Alembic Pharma

ISIN
INE901L01018
Sector Market Cap
₹ 15,668.05 Cr

Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.

Alembic Pharma Financial Highlights

  • Revenue: Alembic Pharma reported revenue of ₹7,399.31 crore in FY26 vs ₹6,714.63 crore in FY25. It showed an increase of 10.20% on a yearly basis.
  • Operating Profit: Alembic Pharma reported an operating profit of ₹693.95 crore in FY26 vs ₹707.18 crore in FY25. It showed a decrease of 1.87% on a year-on-year basis.
  • Net Profit: Alembic Pharma reported a net profit of ₹670.83 crore in FY26 vs ₹582.01 crore in FY25. It showed an increase of 15.26% on a yearly basis.

Alembic Pharma Quarterly Result Highlights

  • Alembic Pharma reported revenue of ₹2,164.70 crore in Jun 2026, compared with ₹1,873.22 crore in Mar 2026, representing an increase of 15.56% on a quarter-on-quarter (QoQ) basis.
  • Alembic Pharma reported an operating profit of ₹221.86 crore in Jun 2026, compared with ₹118.62 crore in Mar 2026, representing an increase of 87.03% on a quarter-on-quarter (QoQ) basis.
  • Alembic Pharma reported a profit of ₹172.36 crore in Jun 2026, compared with ₹201.53 crore in Mar 2026, reflecting a decrease of 14.47% on a QoQ basis.
  • The earnings per share (EPS) of Alembic Pharma stood at ₹34.33 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
69.87%
FII
4.18%
Other DII
7.21%
Retail and other
10.01%
Mutual funds
8.73%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20254.05%
Dec 20254.24%
Mar 20264.25%
Jun 20264.18%
1 day
+1.12%
1 week
-4.36%
1 month
-1.62%
1 year
-15.46%
3 years
-0.38%
5 years
-2.23%
Day
Open / Close
Change %
13 Oct 26
₹787.10 / ₹797.85
+1.12%
12 Oct 26
₹796.95 / ₹789.05
-1.49%
09 Oct 26
₹801.00 / ₹800.95
+0.06%
08 Oct 26
₹833.80 / ₹800.50
-3.99%
Show more

Alembic Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹7,344.90₹6,672.08₹6,228.63₹5,652.62
Other Income₹54.41₹42.55₹28.30₹2.74
Total Revenue₹7,399.31₹6,714.63₹6,256.93₹5,655.36
Total Expenses₹6,638.62₹6,021.20₹5,624.13₹5,269.86
Profit Before Tax₹693.95₹707.18₹631.83₹354.59
Tax₹23.12₹125.17₹16.01₹12.60
Profit After Tax₹670.83₹582.01₹615.82₹341.99
EPS - Basic₹34.33₹29.68₹31.33₹17.40
EPS - Diluted₹34.33₹29.68₹31.33₹17.40

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹693.95₹707.18₹631.83₹354.59
Income before WC changes₹1,143.26₹1,080.71₹918.69₹842.20
Change in Assets-₹265.52-₹1,088.66-₹146.81₹38.70
Change in Liabilities₹8.70₹167.30₹51.17-₹96.26
Change in WC-₹256.82-₹921.36-₹95.64-₹57.56
Cash flow from Operations₹782.73₹87.96₹803.20₹723.95
Cash flow from Investing-₹506.06-₹568.41-₹320.61-₹447.60
Cash flow from Financing-₹163.78₹443.72-₹437.86-₹261.96
Total Cash Flow₹112.89-₹36.73₹44.73₹14.39
Cash (Start of the year)₹83.48₹120.21₹75.48₹61.09
Cash (End of the year)₹196.37₹83.48₹120.21₹75.48

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹4,219.99₹3,685.15₹3,367.02₹3,272.81
Current Assets₹4,542.59₹4,087.80₹3,078.56₹2,910.02
Total Assets₹8,762.58₹7,772.95₹6,445.58₹6,182.83
Current Liabilities₹2,593.83₹2,412.35₹1,454.99₹1,636.93
Net Current Asset₹1,948.76₹1,675.45₹1,623.57₹1,273.09
Non-Current Liabilities₹499.77₹171.08₹172.39₹175.43
Equity Capital₹5,668.98₹5,189.52₹4,818.20₹4,370.47
Total Equity & Liabilities₹8,762.58₹7,772.95₹6,445.58₹6,182.83

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹6,651.38₹6,032.63₹5,874.06₹5,149.00
Other Income₹55.90₹47.88₹31.32₹3.55
Total Revenue₹6,707.28₹6,080.51₹5,905.38₹5,152.55
Total Expenses₹5,986.18₹5,484.79₹5,201.15₹4,806.62
Profit Before Tax₹654.11₹608.59₹704.23₹345.93
Tax₹13.69₹105.47₹37.75-₹0.80
Profit After Tax₹640.42₹503.12₹666.48₹346.73
EPS - Basic₹32.58₹25.60₹33.91₹17.64
EPS - Diluted₹32.58₹25.60₹33.91₹17.64

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹654.11₹608.59₹704.23₹345.93
Income before WC changes₹1,082.56₹973.66₹988.44₹794.42
Change in Assets-₹184.71-₹828.50-₹224.36₹33.82
Change in Liabilities-₹8.84₹127.07₹18.72-₹44.21
Change in WC-₹193.55-₹701.43-₹205.64-₹10.39
Cash flow from Operations₹809.47₹226.56₹772.77₹730.25
Cash flow from Investing-₹483.43-₹636.07-₹329.02-₹460.98
Cash flow from Financing-₹317.60₹403.61-₹445.29-₹261.16
Total Cash Flow₹8.44-₹5.90-₹1.54₹8.11
Cash (Start of the year)₹14.23₹20.13₹21.67₹13.56
Cash (End of the year)₹22.67₹14.23₹20.13₹21.67

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹4,150.24₹3,790.07₹3,409.99₹3,350.19
Current Assets₹4,001.00₹3,766.19₹2,988.56₹2,780.23
Total Assets₹8,151.24₹7,556.26₹6,398.55₹6,130.42
Current Liabilities₹2,356.15₹2,199.59₹1,327.22₹1,551.30
Net Current Asset₹1,644.85₹1,566.60₹1,661.34₹1,228.93
Non-Current Liabilities₹179.83₹161.93₹162.42₹164.83
Equity Capital₹5,615.26₹5,194.74₹4,908.91₹4,414.29
Total Equity & Liabilities₹8,151.24₹7,556.26₹6,398.55₹6,130.42
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
792.45
8
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 8
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
40.76
Neutral
ATR (14)
26.06
Neutral
STOCH(9,6)
19.48
Bullish
STOCH RSI (14)
13.32
Bullish
ADX(9)
26.83
Bearish
UO(9)
48.4
Neutral
ROC(12)
-6.14
Bearish
WillR(14)
-80.52
Bullish
Period
Simple value
Exponential vaue
5D
804.43
803.74
10D
818.98
814.2
20D
830.65
821.74
50D
824.76
820.47
100D
804.52
807.45
Volume trend — traded volume by day
14 Oct0L
13 Oct0L
12 Oct1L
9 Oct1L
8 Oct1L
7 Oct1L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Alembic Pharma
Pharmaceuticals
Add Stock
Add Another

Alembic Pharma Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.